Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CTS vs PLXS vs VICR vs NOVT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CTS
CTS Corporation

Hardware, Equipment & Parts

TechnologyNYSE • US
Market Cap$1.71B
5Y Perf.+180.5%
PLXS
Plexus Corp.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$6.98B
5Y Perf.+306.0%
VICR
Vicor Corporation

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$11.79B
5Y Perf.+328.6%
NOVT
Novanta Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$4.86B
5Y Perf.+32.7%

CTS vs PLXS vs VICR vs NOVT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CTS logoCTS
PLXS logoPLXS
VICR logoVICR
NOVT logoNOVT
IndustryHardware, Equipment & PartsHardware, Equipment & PartsHardware, Equipment & PartsHardware, Equipment & Parts
Market Cap$1.71B$6.98B$11.79B$4.86B
Revenue (TTM)$556M$4.31B$453M$981M
Net Income (TTM)$69M$188M$119M$54M
Gross Margin38.7%10.1%57.3%44.4%
Operating Margin15.9%5.2%18.1%11.9%
Forward P/E24.6x33.8x94.3x38.2x
Total Debt$122M$175M$13M$342M
Cash & Equiv.$82M$307M$403M$381M

CTS vs PLXS vs VICR vs NOVTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CTS
PLXS
VICR
NOVT
StockMay 20May 26Return
CTS Corporation (CTS)100280.5+180.5%
Plexus Corp. (PLXS)100406.0+306.0%
Vicor Corporation (VICR)100428.6+328.6%
Novanta Inc. (NOVT)100132.7+32.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: CTS vs PLXS vs VICR vs NOVT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VICR leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. CTS Corporation is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CTS
CTS Corporation
The Income Pick

CTS is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 1 yrs, beta 1.44, yield 0.3%
  • Lower volatility, beta 1.44, Low D/E 22.1%, current ratio 2.30x
  • PEG 1.58 vs NOVT's 11.61
  • Beta 1.44, yield 0.3%, current ratio 2.30x
Best for: income & stability and sleep-well-at-night
PLXS
Plexus Corp.
The Quality Angle

PLXS plays a supporting role in this comparison — it may shine differently against other peers.

Best for: technology exposure
VICR
Vicor Corporation
The Growth Play

VICR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 13.5%, EPS growth 17.6%, 3Y rev CAGR 0.7%
  • 27.0% 10Y total return vs PLXS's 5.2%
  • 13.5% revenue growth vs PLXS's 1.8%
  • 26.2% margin vs PLXS's 4.4%
Best for: growth exposure and long-term compounding
NOVT
Novanta Inc.
The Secondary Option

NOVT lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: technology exposure
See the full category breakdown
CategoryWinnerWhy
GrowthVICR logoVICR13.5% revenue growth vs PLXS's 1.8%
ValueCTS logoCTSLower P/E (24.6x vs 38.2x), PEG 1.58 vs 11.61
Quality / MarginsVICR logoVICR26.2% margin vs PLXS's 4.4%
Stability / SafetyCTS logoCTSBeta 1.44 vs VICR's 2.79
DividendsCTS logoCTS0.3% yield; 1-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)VICR logoVICR+5.4% vs NOVT's +14.6%
Efficiency (ROA)VICR logoVICR16.6% ROA vs NOVT's 3.0%, ROIC 8.9% vs 7.4%

CTS vs PLXS vs VICR vs NOVT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CTSCTS Corporation
FY 2012
Components and Sensors Segment
52.8%$304M
EMS Segment
47.2%$272M
PLXSPlexus Corp.
FY 2025
Asia Pacific Segment
59.1%$2.4B
Americas Segment
30.0%$1.2B
EMEA Segment
10.9%$440M
VICRVicor Corporation
FY 2025
AdvancedProducts
61.0%$249M
BrickProducts
39.0%$159M
NOVTNovanta Inc.
FY 2025
Robotics and Automation
32.5%$319M
Advanced Surgery
24.7%$242M
Precision Medicine
24.2%$237M
Precision Manufacturing
18.6%$182M

CTS vs PLXS vs VICR vs NOVT — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCTSLAGGINGNOVT

Income & Cash Flow (Last 12 Months)

VICR leads this category, winning 5 of 6 comparable metrics.

PLXS is the larger business by revenue, generating $4.3B annually — 9.5x VICR's $453M. VICR is the more profitable business, keeping 26.2% of every revenue dollar as net income compared to PLXS's 4.4%. On growth, PLXS holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCTS logoCTSCTS CorporationPLXS logoPLXSPlexus Corp.VICR logoVICRVicor CorporationNOVT logoNOVTNovanta Inc.
RevenueTrailing 12 months$556M$4.3B$453M$981M
EBITDAEarnings before interest/tax$123M$261M$103M$179M
Net IncomeAfter-tax profit$69M$188M$119M$54M
Free Cash FlowCash after capex$88M$76M$119M$48M
Gross MarginGross profit ÷ Revenue+38.7%+10.1%+57.3%+44.4%
Operating MarginEBIT ÷ Revenue+15.9%+5.2%+18.1%+11.9%
Net MarginNet income ÷ Revenue+12.4%+4.4%+26.2%+5.5%
FCF MarginFCF ÷ Revenue+15.8%+1.8%+26.3%+4.9%
Rev. Growth (YoY)Latest quarter vs prior year+10.9%+18.7%+11.5%+8.5%
EPS Growth (YoY)Latest quarter vs prior year+34.1%+29.1%+3.4%-2.2%
VICR leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

CTS leads this category, winning 6 of 7 comparable metrics.

At 27.3x trailing earnings, CTS trades at a 73% valuation discount to VICR's 100.1x P/E. Adjusting for growth (PEG ratio), CTS offers better value at 1.75x vs NOVT's 28.13x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCTS logoCTSCTS CorporationPLXS logoPLXSPlexus Corp.VICR logoVICRVicor CorporationNOVT logoNOVTNovanta Inc.
Market CapShares × price$1.7B$7.0B$11.8B$4.9B
Enterprise ValueMkt cap + debt − cash$1.8B$6.9B$11.4B$4.8B
Trailing P/EPrice ÷ TTM EPS27.33x41.65x100.13x92.71x
Forward P/EPrice ÷ next-FY EPS est.24.63x33.84x94.31x38.25x
PEG RatioP/E ÷ EPS growth rate1.75x4.27x2.23x28.13x
EV / EBITDAEnterprise value multiple14.68x24.46x197.81x27.00x
Price / SalesMarket cap ÷ Revenue3.16x1.73x28.91x4.96x
Price / BookPrice ÷ Book value/share3.23x4.95x16.50x3.81x
Price / FCFMarket cap ÷ FCF19.82x45.36x98.86x100.38x
CTS leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

VICR leads this category, winning 5 of 9 comparable metrics.

VICR delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $4 for NOVT. VICR carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to NOVT's 0.26x. On the Piotroski fundamental quality scale (0–9), PLXS scores 9/9 vs NOVT's 5/9, reflecting strong financial health.

MetricCTS logoCTSCTS CorporationPLXS logoPLXSPlexus Corp.VICR logoVICRVicor CorporationNOVT logoNOVTNovanta Inc.
ROE (TTM)Return on equity+12.5%+12.8%+18.7%+4.1%
ROA (TTM)Return on assets+8.9%+5.9%+16.6%+3.0%
ROICReturn on invested capital+11.1%+11.8%+8.9%+7.4%
ROCEReturn on capital employed+12.8%+12.9%+5.7%+8.3%
Piotroski ScoreFundamental quality 0–97975
Debt / EquityFinancial leverage0.22x0.12x0.02x0.26x
Net DebtTotal debt minus cash$40M-$131M-$390M-$39M
Cash & Equiv.Liquid assets$82M$307M$403M$381M
Total DebtShort + long-term debt$122M$175M$13M$342M
Interest CoverageEBIT ÷ Interest expense18.18x19.62x4.89x
VICR leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

VICR leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in VICR five years ago would be worth $30,126 today (with dividends reinvested), compared to $10,573 for NOVT. Over the past 12 months, VICR leads with a +535.7% total return vs NOVT's +14.6%. The 3-year compound annual growth rate (CAGR) favors VICR at 82.5% vs NOVT's -5.3% — a key indicator of consistent wealth creation.

MetricCTS logoCTSCTS CorporationPLXS logoPLXSPlexus Corp.VICR logoVICRVicor CorporationNOVT logoNOVTNovanta Inc.
YTD ReturnYear-to-date+36.6%+71.3%+123.6%+22.6%
1-Year ReturnPast 12 months+53.2%+107.2%+535.7%+14.6%
3-Year ReturnCumulative with dividends+44.5%+201.9%+507.9%-15.2%
5-Year ReturnCumulative with dividends+83.2%+174.0%+201.3%+5.7%
10-Year ReturnCumulative with dividends+253.2%+515.8%+2704.1%+853.7%
CAGR (3Y)Annualised 3-year return+13.1%+44.5%+82.5%-5.3%
VICR leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CTS leads this category, winning 2 of 2 comparable metrics.

CTS is the less volatile stock with a 1.44 beta — it tends to amplify market swings less than VICR's 2.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTS currently trades 98.4% from its 52-week high vs VICR's 88.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCTS logoCTSCTS CorporationPLXS logoPLXSPlexus Corp.VICR logoVICRVicor CorporationNOVT logoNOVTNovanta Inc.
Beta (5Y)Sensitivity to S&P 5001.44x1.65x2.79x2.02x
52-Week HighHighest price in past year$60.81$275.83$293.95$149.95
52-Week LowLowest price in past year$36.03$115.35$40.27$98.27
% of 52W HighCurrent price vs 52-week peak+98.4%+94.5%+88.9%+90.9%
RSI (14)Momentum oscillator 0–10071.074.268.262.6
Avg Volume (50D)Average daily shares traded209K344K864K375K
CTS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CTS leads this category, winning 1 of 1 comparable metric.

Analyst consensus: CTS as "Hold", PLXS as "Buy", VICR as "Buy", NOVT as "Buy". Consensus price targets imply 10.1% upside for NOVT (target: $150) vs -6.3% for VICR (target: $245). CTS is the only dividend payer here at 0.27% yield — a key consideration for income-focused portfolios.

MetricCTS logoCTSCTS CorporationPLXS logoPLXSPlexus Corp.VICR logoVICRVicor CorporationNOVT logoNOVTNovanta Inc.
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$251.25$245.00$150.00
# AnalystsCovering analysts41873
Dividend YieldAnnual dividend ÷ price+0.3%
Dividend StreakConsecutive years of raises100
Dividend / ShareAnnual DPS$0.16
Buyback YieldShare repurchases ÷ mkt cap+3.3%+0.9%+0.3%+0.8%
CTS leads this category, winning 1 of 1 comparable metric.
Key Takeaway

VICR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CTS leads in 3 (Valuation Metrics, Risk & Volatility).

Best OverallCTS Corporation (CTS)Leads 3 of 6 categories
Loading custom metrics...

CTS vs PLXS vs VICR vs NOVT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CTS or PLXS or VICR or NOVT a better buy right now?

For growth investors, Vicor Corporation (VICR) is the stronger pick with 13.

5% revenue growth year-over-year, versus 1. 8% for Plexus Corp. (PLXS). CTS Corporation (CTS) offers the better valuation at 27. 3x trailing P/E (24. 6x forward), making it the more compelling value choice. Analysts rate Plexus Corp. (PLXS) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CTS or PLXS or VICR or NOVT?

On trailing P/E, CTS Corporation (CTS) is the cheapest at 27.

3x versus Vicor Corporation at 100. 1x. On forward P/E, CTS Corporation is actually cheaper at 24. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CTS Corporation wins at 1. 58x versus Novanta Inc. 's 11. 61x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — CTS or PLXS or VICR or NOVT?

Over the past 5 years, Vicor Corporation (VICR) delivered a total return of +201.

3%, compared to +5. 7% for Novanta Inc. (NOVT). Over 10 years, the gap is even starker: VICR returned +27. 0% versus CTS's +253. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CTS or PLXS or VICR or NOVT?

By beta (market sensitivity over 5 years), CTS Corporation (CTS) is the lower-risk stock at 1.

44β versus Vicor Corporation's 2. 79β — meaning VICR is approximately 94% more volatile than CTS relative to the S&P 500. On balance sheet safety, Vicor Corporation (VICR) carries a lower debt/equity ratio of 2% versus 26% for Novanta Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CTS or PLXS or VICR or NOVT?

By revenue growth (latest reported year), Vicor Corporation (VICR) is pulling ahead at 13.

5% versus 1. 8% for Plexus Corp. (PLXS). On earnings-per-share growth, the picture is similar: Vicor Corporation grew EPS 1764% year-over-year, compared to -16. 9% for Novanta Inc.. Over a 3-year CAGR, NOVT leads at 4. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CTS or PLXS or VICR or NOVT?

Vicor Corporation (VICR) is the more profitable company, earning 29.

1% net margin versus 4. 3% for Plexus Corp. — meaning it keeps 29. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTS leads at 15. 6% versus 5. 0% for PLXS. At the gross margin level — before operating expenses — VICR leads at 52. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CTS or PLXS or VICR or NOVT more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CTS Corporation (CTS) is the more undervalued stock at a PEG of 1. 58x versus Novanta Inc. 's 11. 61x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, CTS Corporation (CTS) trades at 24. 6x forward P/E versus 94. 3x for Vicor Corporation — 69. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NOVT: 10. 1% to $150. 00.

08

Which pays a better dividend — CTS or PLXS or VICR or NOVT?

In this comparison, CTS (0.

3% yield) pays a dividend. PLXS, VICR, NOVT do not pay a meaningful dividend and should not be held primarily for income.

09

Is CTS or PLXS or VICR or NOVT better for a retirement portfolio?

For long-horizon retirement investors, CTS Corporation (CTS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+253.

2% 10Y return). Vicor Corporation (VICR) carries a higher beta of 2. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CTS: +253. 2%, VICR: +27. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CTS and PLXS and VICR and NOVT?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CTS

Steady Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

PLXS

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 9%
Run This Screen
Stocks Like

VICR

Quality Mega-Cap Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 15%
Run This Screen
Stocks Like

NOVT

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CTS and PLXS and VICR and NOVT on the metrics below

Revenue Growth>
%
(CTS: 10.9% · PLXS: 18.7%)
Net Margin>
%
(CTS: 12.4% · PLXS: 4.4%)
P/E Ratio<
x
(CTS: 27.3x · PLXS: 41.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.